| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/06/2008 | US7368428 Contacting tumor cells to glycoprtorein 88 (GP88) antagonists (e.g., anti-GP88 antibodies, anti-GP88 antisense nucleic acids, GP88 siRNA, and small molecules); antiestrogen and cytotoxic therapy |
| 05/06/2008 | US7368287 For treatment and/or prevention of inflammation and autoimmune disease; vaccines |
| 05/06/2008 | US7368261 Conserved Neisserial antigens |
| 05/06/2008 | US7368250 Using monoclonal antibody specific to tumor cell as diagnostic and therapeutic tool in detection and treatment of cancer; immunodiagnostics; immunotherapy |
| 05/06/2008 | US7368136 Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 05/06/2008 | US7368119 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 05/06/2008 | US7368118 gene expression vector comprising polynucleotides that code polypeptides, used to define epitopes that stimulate human leukocyte antigens, for prophylaxis of viral diseases |
| 05/06/2008 | US7368117 Porcine Respiratory Reproductive Syndrome (PRRS); viral disease affecting pigs |
| 05/06/2008 | US7368116 Method of enhancing a targeted immune response against tumors |
| 05/06/2008 | US7368114 CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin containing a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. |
| 05/06/2008 | US7368112 Antibody binding to polypeptide of given sequence; antisera; use in wound healing, blocking adherence to indwelling medical devices, vaccines |
| 05/06/2008 | US7368111 Immunoglobulin for use in diagnosis, prevention and treatment of autoimmune, immunological and inflammatory disorders; immunotherapy |
| 05/06/2008 | US7368110 Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 05/06/2008 | US7368109 For ameliorating acquired immunodeficiency syndrome (AIDS), an antoimmune disease, or graft rejection |
| 05/06/2008 | US7368107 Tumor antigen peptides derived from cyclophilin B |
| 05/06/2008 | US7368106 Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | CA1341572C Protective antibodies to serotypic determinants of flagellar antigens |
| 05/02/2008 | WO2008052187A2 Antibodies and immunoconjugates and uses therefor |
| 05/02/2008 | WO2008052173A2 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| 05/02/2008 | WO2008052165A2 Method for treating pathological pulmonary conditions and bleomycin associated pulmonary fibrosis |
| 05/02/2008 | WO2008052111A2 Resistin antagonists and their use |
| 05/02/2008 | WO2008051980A2 Methods of reducing phosphate absorption |
| 05/02/2008 | WO2008051977A2 Methods of reducing phosphate absorption |
| 05/02/2008 | WO2008051852A2 Extracellular matrix cancer vaccine adjuvant |
| 05/02/2008 | WO2008051424A2 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators |
| 05/02/2008 | WO2008051363A2 Stable polypeptide formulations |
| 05/02/2008 | WO2008051326A2 Identification of contactins and l1- cams as ligands for the amyloid precursor protein |
| 05/02/2008 | WO2008051245A2 Nanoparticles for use in immunogenic compositions |
| 05/02/2008 | WO2008050907A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/02/2008 | WO2008049990A2 Use of an anti-cd151 antibody in the treatment of cancer |
| 05/02/2008 | WO2008049928A1 Anti-glycoprotein vi scfv fragment for treatment of thrombosis |
| 05/02/2008 | WO2008049897A1 Intranasal delivery of polypeptides and proteins |
| 05/02/2008 | WO2008049888A1 Use of measles virus nucleoprotein for treating atherosclerosis |
| 05/02/2008 | WO2008049881A2 Polypeptides and pharmaceutical compositions comprising the same for the prevention and treatment of complications associated with infectious diseases |
| 05/02/2008 | WO2008049643A2 Gd2 peptide mimotopes for anticancer vaccination |
| 05/02/2008 | WO2008049424A2 Pharmaceutical composition for the treatment of allergic diseases |
| 05/02/2008 | WO2008049329A1 Hpv antigen fusion protein vaccine compositions and uses thereof |
| 05/02/2008 | WO2008049231A1 Tissue targeted antigenic activation of the immune response to treat cancers |
| 05/02/2008 | WO2008049226A1 Inhibition of sox9 function fn the treatment of proteogl ycan-associated pathophysiological conditions |
| 05/02/2008 | WO2008030706A3 Anti-myostatin antibodies |
| 05/02/2008 | WO2008028977A3 Serum albumin binding proteins with long half-lives |
| 05/02/2008 | WO2008019326A3 Ephb3-specific antibody and uses thereof |
| 05/02/2008 | WO2008013797A8 Compositions and methods for macular degeneration |
| 05/02/2008 | WO2008010864A3 Modified adenovirus hexon protein and uses thereof |
| 05/02/2008 | WO2007149932A3 Methods and compositions for targeting hepsin |
| 05/02/2008 | WO2007145862B1 Extending survival of cancer patients with elevated levels of egf or tgf-alpha |
| 05/02/2008 | WO2007144619A3 Antibodies selectively binding aggregated prion protein 106-126 and uses thereof |
| 05/02/2008 | WO2007144316A3 Vaccine |
| 05/02/2008 | WO2007130697A8 Anti-ephb4 antibodies and methods using same |
| 05/02/2008 | WO2007120309A3 Attenuated brucella melitensis mutants |
| 05/02/2008 | WO2007112386A3 Gdf-9/bmp-15 modulators for the treatment of bone disorders |
| 05/02/2008 | WO2007112316A3 Mycobacterial immunotherapy for cancer treatment |
| 05/02/2008 | WO2007111714B1 Il-21 antagonists |
| 05/02/2008 | WO2007105115A3 Compositions and methods for immunisation using cd1d ligands |
| 05/02/2008 | WO2007097989A3 A composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer |
| 05/02/2008 | WO2007089870A3 Vaccine delivery compositions and methods of use |
| 05/02/2008 | WO2007089612A3 Methods and compositions for treating and preventing bacterial infections |
| 05/02/2008 | WO2007084237A3 Novel synthetic agonists of toll-like receptors containing cg dinucleotide modifications |
| 05/02/2008 | WO2007082173A3 Compositions and methods for enhancing the identification of prion protein prpsc |
| 05/02/2008 | WO2007067780A3 Combination therapy and antibody panels |
| 05/02/2008 | WO2007045477A8 Human antibodies against il-13 and therapeutic uses |
| 05/02/2008 | WO2007028574A9 Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules |
| 05/02/2008 | WO2007028573A9 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 05/02/2008 | WO2005084329A8 Method for inhibiting tumor formation and growth |
| 05/02/2008 | CA2667582A1 Method of treating conditions associated with proteoglycan production |
| 05/02/2008 | CA2667466A1 Intranasal delivery of polypeptides and proteins |
| 05/02/2008 | CA2667263A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/02/2008 | CA2667075A1 Extracellular matrix cancer vaccine adjuvant |
| 05/02/2008 | CA2667020A1 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators |
| 05/02/2008 | CA2667019A1 Antibodies and immunoconjugates and uses therefor |
| 05/02/2008 | CA2666672A1 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 05/02/2008 | CA2665912A1 Use of an anti-cd151 antibody in the treatment of cancer |
| 05/02/2008 | CA2664914A1 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| 05/02/2008 | CA2663536A1 Materials and methods for improved immunoglycoproteins |
| 05/02/2008 | CA2642559A1 A dengue reporter virus and methods of making and using the same |
| 05/02/2008 | CA2631714A1 Nanoparticles for use in immunogenic compositions |
| 05/01/2008 | US20080103109 Distributing polynucleotide in vivo using conditional vector that is transcriptionally active in normal cells and not in malfunctioning cells |
| 05/01/2008 | US20080103095 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 05/01/2008 | US20080102507 Nutrient broth comprising chicken embryo particles for production of viral antigen; vaccine development |
| 05/01/2008 | US20080102112 Chlamydia vaccines |
| 05/01/2008 | US20080102091 Vaccines |
| 05/01/2008 | US20080102090 Mixture with surfactant; therapy for muscular paralysis; greater intramuscular safety margin; selective action on inhibition of pain-related (nociceptive) nerve cell function |
| 05/01/2008 | US20080102089 topical application of a composition of urea and a chemotherapeutic agent such as sclerosing agents, vasodilators and botulinum toxin; spider veins, erectile dysfunction and facial wrinkles |
| 05/01/2008 | US20080102088 against tularemia; subcellular protein expressed from Francisella tularensis infected mammal subculture growing in synthetic salts medium of weak acidity |
| 05/01/2008 | US20080102087 Compositions and methods for vaccinating against hsv-2 |
| 05/01/2008 | US20080102086 Feline Influenza Vaccine and Method of Use |
| 05/01/2008 | US20080102085 Vaccines for treatment of Aids; protein or polynucleotide is delivered via a bombardment approach |
| 05/01/2008 | US20080102084 Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin |
| 05/01/2008 | US20080102083 Compositions and Methods for the Preparation of Human Growth Hormone Glycosylation Mutants |
| 05/01/2008 | US20080102080 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 05/01/2008 | US20080102079 Poultry Vaccine, for Necrotic Enteritis, Comprising a Mutated Clostridium Perfringens Alpha Toxin Antigen, and Methods of Producing the Vaccine |
| 05/01/2008 | US20080102078 Mutated e. coli heat-labile enterotoxin |
| 05/01/2008 | US20080102077 Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof |
| 05/01/2008 | US20080102076 Immunostimulatory Compositions and Uses Thereof |
| 05/01/2008 | US20080102074 Comprises selenium, copper, zinc, manganese and/or chromium, and EDTA |
| 05/01/2008 | US20080102073 Antigen-Antibody Complexes as HIV-1 Vaccines |
| 05/01/2008 | US20080102072 Cytokine specific immunoglobulin for prevention and treatment of diabetes, autoimmune and inflammatory disorders |
| 05/01/2008 | US20080102071 T cell inhibitory receptor compositions and uses thereof |
| 05/01/2008 | US20080102070 SCDs As Modifiers of the p53 Pathway and Methods of Use |